Panel proposes framework for FDA to evaluate drug risks

被引：0
|
作者：
Stokes, Trevor
机构：
来源：
NATURE MEDICINE | 2012年 / 18卷 / 06期
关键词：
D O I：
10.1038/nm0612-839b
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：839 / 839
页数：1
相关论文
共 50 条
  • [41] FDA proposes rules on dietary supplements
    不详
    CHEMICAL & ENGINEERING NEWS, 2003, 81 (11) : 27 - 27
  • [42] US Food and Drug Administration (FDA) proposes health claim for oatmeal and oat bran
    不详
    NUTRITION REVIEWS, 1996, 54 (02) : 69 - 69
  • [43] Panel proposes disarmament guide
    Pockley, P
    NATURE, 1996, 382 (6593) : 663 - 663
  • [44] A framework to evaluate systemic risks of inland waterway infrastructure
    Wehrle, Rebecca
    Wiens, Marcus
    Schultmann, Frank
    PROGRESS IN DISASTER SCIENCE, 2022, 16
  • [45] Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications
    Kesselheim, Aaron S.
    Campbell, Eric G.
    Schneeweiss, Sebastian
    Rausch, Paula
    Lappin, Brian M.
    Zhou, Esther H.
    Seeger, John D.
    Brownstein, John S.
    Woloshin, Steven
    Schwartz, Lisa M.
    Toomey, Timothy
    Dal Pan, Gerald J.
    Avorn, Jerry
    DRUG SAFETY, 2015, 38 (06) : 565 - 575
  • [46] Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications
    Aaron S. Kesselheim
    Eric G. Campbell
    Sebastian Schneeweiss
    Paula Rausch
    Brian M. Lappin
    Esther H. Zhou
    John D. Seeger
    John S. Brownstein
    Steven Woloshin
    Lisa M. Schwartz
    Timothy Toomey
    Gerald J. Dal Pan
    Jerry Avorn
    Drug Safety, 2015, 38 : 565 - 575
  • [47] DRUG POLICY - FDA PANEL BACKS INTERLEUKIN-2
    CULLITON, BJ
    NATURE, 1992, 355 (6358) : 287 - 287
  • [48] FDA panel says preterm birth drug should be withdrawn
    Jaffe, Susan
    LANCET, 2022, 400 (10362): : 1501 - 1501
  • [49] FDA panel advises against omeprazole as over the counter drug
    Gottlieb, S
    BRITISH MEDICAL JOURNAL, 2000, 321 (7269): : 1099 - 1099
  • [50] US FDA warns of serious risks with psoriasis drug Raptiva®
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (04) : 393 - 394
12345